Advertisement
The U.S. Food and Drug Administration has approved Roche's cobas HPV Test as the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid.

Approval of First HPV Test for Use With SurePath Preservative Fluid

0
For cervical cells obtained for Pap test, collected in SurePath Preservative Fluid
An elderly resident of Utah who died at the end of June is the first fatality in the continental United States linked to infection with the Zika virus

Utah Resident Is First Zika-Linked Death in Continental U.S.

0
Patient had an underlying medical condition and tested positive for Zika
The majority of cancers linked to human papillomavirus are preventable

CDC: Majority of HPV-Linked Cancers Are Preventable

0
Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers
Detection of circulating tumor DNA after resection of stage II colon cancer may identify patients at increased risk of recurrence

Circulating Tumor DNA May Help Predict Colon CA Recurrence

0
Findings in patients after resection of stage II colon cancer
The U.S. Department of Veterans Affairs is appealing to physicians to join the agency as part of its recovery from a 2014 scandal linked to excessive wait times

VA Appealing to Physicians to Join Agency

0
Key efforts in response to 2014 scandal include reducing wait times, engaging employees
Short-term survival of heritable retinoblastoma is high

Retinoblastoma Mortality Up With Eye-Preserving Radiotherapy

0
Second malignancies remain major cause of death in retinoblastoma survivors
A new study indicates that 8 percent of patients -- or one in 12 -- already diagnosed with one form of cancer will develop a second type of unrelated cancer. The findings were published online  July 5 in Cancer.

Second, Unrelated Malignancies Strike 1 in 12 Cancer Patients

0
Second cancer was fatal in 55 percent of the cases studied
A metabolomics signature can predict the transition from gestational diabetes mellitus to type 2 diabetes

Metabolomics Signature Can Predict GDM to T2DM Transition

0
Metabolomics with baseline fasting plasma could predict transition from gestational diabetes to T2DM
Patients with myalgic encephalomyelitis/chronic fatigue syndrome have reduced diversity and altered composition of the gut microbiome

Reduced Microbiome Diversity in Myalgic Encephalopathy/CFS

0
Increase in species described as pro-inflammatory, decrease in those identified as anti-inflammatory
A blood test based on gene responses may help differentiate between bacterial and viral infections

Blood Test Might Help Diagnose Viral Versus Bacterial Infection

0
The screen could one day provide results in an hour, developers say